Glaxosmithkline

Generation NCD: Searching For the Scientists to Tackle Africa's Next Healthcare Challenge

James Shannon | Posted 27.07.2014 | UK
James Shannon

Africa and its healthcare needs are changing. As its economic landscape shifts, burgeoning wealth co-exists with extreme poverty. While infectious diseases like malaria and HIV still place huge pressure on Africa, non-communicable diseases (NCDs) such as cancer and diabetes pose an increasing threat.

UK Fraud Squad Probes Drugs Giant GSK

PA | Posted 28.05.2014 | UK

Drugs giant GlaxoSmithKline's commercial practices are under criminal investigation by the UK's major fraud unit, the company said. The London-base...

Extreme Collaboration: How Charity and Business Can Work Together

Allan Pamba | Posted 19.07.2014 | UK
Allan Pamba

Partnerships of any kind - be they romantic or professional - are never straightforward. There are differences of opinion that it can be difficult to reconcile and different ways of working can cause tension...

The Pfizer Deal Touches Us All

Margaret Heffernan | Posted 11.07.2014 | UK
Margaret Heffernan

Most mergers and acquisitions don't work. With a failure rate anywhere between 50 and 80 percent, they're bad bets usually placed by leaders who've run out of ideas. This one is no different...

Three Ideas to Accelerate the Fight Against Malaria

Allan Pamba | Posted 24.06.2014 | UK
Allan Pamba

Malaria is obstinate. A massive effort by the international community along with the determination of committed individuals, scientists, health workers , governments, charities and other organisations have made a huge dent on its impact. Globally, cases are down 25%, deaths are down 42% since 2000 - but malaria is far from gone.

The Road From Aid to Trade: Investing in a Healthier Future for Africa

Allan Pamba | Posted 09.06.2014 | UK
Allan Pamba

At the EU-Africa business summit I attended last week, a question that I heard again and again is what are the barriers to investing more in sub-Saharan Africa?

To Combat Cancer in Developing Countries, We Must Learn The Lessons of HIV And Malaria

Allan Pamba | Posted 08.04.2014 | UK
Allan Pamba

Think of disease in Africa and you maybe think of malaria. But this is not the whole picture. In Africa and across developing countries, people are living longer and their lifestyles are changing. With this shift, a different threat is emerging...

Cameron Risks Tensions With China

The Huffington Post UK | Asa Bennett | Posted 02.12.2013 | UK Politics

David Cameron may risk diplomatic tensions by bringing Sir Andrew Witty, CEO of GlaxoSmithKline on his trade mission to China, while the pharmaceutica...

Developing Countries Are Finding Innovative Solutions to Their Health Challenges

Allan Pamba | Posted 25.01.2014 | UK
Allan Pamba

Malawi might not spring to mind as a hot-bed of healthcare innovation. Neither might Bangladesh or Colombia. But that view is changing. All over developing countries, determined people are finding brilliant and creative solutions for long-standing problems. ..

Innovation in the Name of Global Partnership: What the Private Sector Must Bring to the Post-2015 Development Agenda

Duncan Learmouth | Posted 24.09.2013 | UK
Duncan Learmouth

The shortage of health workers is one of the most fundamental barriers to improving health in developing countries. A fully trained and well-supported community health worker like Saley can deliver treatments and provide health education to 5,000 children a year.

Who Could Be Lucozade And Ribena's New Owners?

The Huffington Post UK | Asa Bennett | Posted 06.09.2013 | UK

GlaxoSmithKline, owners of Lucozade and Ribena, is in "advanced talks" to sell the two drink brands to the Japanese group Suntory Beverage & Food in a...

Father-Of-Two Awarded £160,000 After Parkinson's Drug 'Turned Him Into A Gay Sex & Gambling Addict'

Huffington Post UK | Sara C Nelson | Posted 29.11.2012 | UK

A man has been awarded £160,000 in compensation after a drug he took to treat Parkinson's disease turned him into a gay sex and gambling addict. ...

FTSE Chief Pay Up 12% To £4.8m

PA/The Huffington Post UK | Posted 12.06.2012 | UK

The row over executive pay was reignited on Tuesday after it emerged that rewards for blue-chip bosses rose 12% to an average of £4.8 million last ye...

'The Medicines Of The Future Will Be Made In Britain'

PA | Posted 22.03.2012 | UK

Pharmaceuticals giant GlaxoSmithKline unveiled plans to build its first new manufacturing facility in the UK in almost 40 years today. The proposed...

Government Accused Of Delaying New Cancer Drugs 'To Save Money'

PA/Huffington Post UK | Posted 25.02.2012 | UK

The head of Britain biggest drugs company, GlaxoSmithKIine, has accused the government of delaying the introduction of new cancer drugs to save money....

Parents Blame Swine Flu Vaccine For Child's Narcolepsy

The Huffington Post UK | Kyrsty Hazell | Posted 13.12.2011 | UK Lifestyle

A mother whose six-year-old son developed narcolepsy three weeks after he had the swine flu vaccine claims the jab triggered the illness. Caroline ...

Malaria Vaccine Trial Offers 'Real Hope'

PA | Posted 18.12.2011 | UK

Scientists in Britain have welcomed news that a trial of a vaccine for malaria has halved the number of cases in young children. Interim results of...